Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes

Journal of NeuroVirology

Volumn 9, Issue 3, 2003, Pages 358-371

  Galey, D ^a   Becker, K ^b   Haughey, N ^a   Kalehua, A ^b   Taub, D ^b   Woodward, J ^c   Mattson, M P ^b   Nath, Avi ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Astrocyte; Chemokine; Cytokine; gp120; HIV; Microarray; RPA; Transcription

Indexed keywords

CHEMOKINE; CYTOKINE; DNA; GLYCOPROTEIN GP 120; OLIGONUCLEOTIDE; VIRUS PROTEIN;

ARTICLE; ASTROCYTE; CELL FUNCTION; CONTROLLED STUDY; DEMENTIA; DNA DETERMINATION; DNA MICROARRAY; EXPOSURE; FETUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MODULATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; RIBONUCLEASE PROTECTION ASSAY; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038784588     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390201119     Document Type: Article

References (32)

1. Bouhlal H, Galon J, Kazatchkine MD, Fridman WH, Sautes-Fridman C, Haeffner Cavaillon N (2001). Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J Immunol 166: 3377-3383.
2. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Metivier D, Este JA, Piacentini M, Kroemer G (2001). Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 194: 1097-1110.
3. Chang TL, Mosoian A, Pine R, Klotman ME, Moore JP (2002). A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol 76: 569-581.
4. Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV associated neurological diseases. J Biol Chem 272: 22385-22388.
5. Chiao C, Bader T, Stenger JE, Baldwin W, Brady J, Barrett JC (2001). HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. AIDS Res Hum Retroviruses 17: 1125-1132.
6. Cicala C, Arthos J, Selig SM, Dennis G Jr, Hosack DA, Van Ryk D, Spangler ML, Steenbeke TD, Khazanie P, Gupta N, Yang J, Daucher M, Lempicki RA, Fauci AS (2002). HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A 99: 9380-9385.
7. Corry DB, Tuck ML (2001). Selective aspects of the insulin resistance syndrome. Curr Opin Nephrol Hypertens 10: 507-514.
8. Furer M, Hartloper V, Wilkins J, Nath A (1993). Lymphocyte emperipolesis in human glial cells. Cell Adhes Commun 1: 223-237.
9. Geiss GK, Bumgarner RE, An MC, Agy MB, van't Wout AB, Hammersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG (2000). Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266: 8-16.
10. Gekker G, Lokensgard JR, Peterson PK (2001). Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4(+) lymphocyte cultures. Drug Alcohol Depend 64: 257-263.
11. Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF (2001). Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102: 555-563.
12. Holden CP, Nath A, Haughey NJ, Geiger JD (1999). Involvement of Na+/H+ exchangers, Ca2+ channels, and excitatory amino acid receptors in intracellular Ca2+ responses to HIV-1 gp120 in cultured human fetal brain cells. Neuroscience 91: 1369-1378.
13. Le Y, Shen W, Li B, Gong W, Dunlop NM, Wang JM (1999). A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. Forum (Genova) 9: 299-314.
14. Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499.
15. Mothe AJ, Brown IR (2000). Selective transport of SC1 mRNA, encoding a putative extracellular matrix glycoprotein, during postnatal development of the rat cerebellum and retina. Brain Res Mol Brain Res 76: 73-84.
16. Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC (2000). Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 25: 312-321.
17. Nath A (1999). Pathobiology of HIV dementia. Semin Neural 19: 113-128.
18. Nath A, Conant K, Chen P, Scott C, Major EO (1999). Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: A hit and run phenomenon. J Biol Chem 274: 17098-17102.
19. Nath A, Geiger JD (1998). Neurobiological Aspects of HIV infections: neurotoxic mechanisms. Prog Neurobiol 54: 19-33.
20. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000a). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47: 186-194.
21. Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE (2001). HIV-1 tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 167: 2766-2771.
22. Peterson PK, Molitor TW, Chao CC (1998). The opioid-cytokine connection. J Neuroimmunol 83: 63-69.
23. Petit F, Arnoult D, Lelievre JD, Moutouh-de Parseval L, Hance AJ, Schneider P, Corbeil J, Ameisen JC, Estaquier J (2002). Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J Biol Chem 277: 1477-1487.
24. Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184: 699-706.
25. Sarol LC, Imai K, Asamitsu K, Tetsuka T, Barzaga NG, Okamoto T (2002). Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells. Biochem Biophys Res Commun 291: 890-896.
26. Sato C, Matsuda T, Kitajima K (2002). Neuronal differentiation-dependent expression of the disialic acid epitope on C-1D166 and its involvement in neurite formation in Neuro2A cells. J Biol Chem 277: 45299-45305.
27. Shen W, Proost P, Li B, Gong W, Le Y, Sargeant R, Murphy PM, Van Damme J, Wang JM (2000). Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem Biophys Res Commun 272: 276-283.
28. Shrikant P, Benos DJ, Tang LP, Benveniste EN (1996). HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 156: 1307-1314.
29. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB (2002). Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602.
30. Takanaga H, Ohtsuki S, Hosoya K, Terasaki T (2001). GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 21: 1232-1239.
31. Tornatore C, Nath A, Amemiya K, Major EO (1991). Persistent HIV-1 infection in human fetal glial cells reactivated by T cell factor(s) or cytokines tumor necrosis factor-alpha and interleukin-1 beta. J Virol 65: 6094-6100.
32. Vidal VF, Casteran N, Riendeau CJ, Kornfeld H, Darcissac EC, Capron A, Bahr GM (2001). Macrophage stimulation with murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-related kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4. Eur J Immunol 31: 1962-1971.